(NASDAQ: QTRX) Quanterix's forecast annual revenue growth rate of 23.68% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.76%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23.93%.
Quanterix's revenue in 2026 is $130,203,000.On average, 6 Wall Street analysts forecast QTRX's revenue for 2026 to be $8,139,356,377, with the lowest QTRX revenue forecast at $7,260,259,178, and the highest QTRX revenue forecast at $8,681,201,622. On average, 6 Wall Street analysts forecast QTRX's revenue for 2027 to be $9,265,086,585, with the lowest QTRX revenue forecast at $8,661,115,980, and the highest QTRX revenue forecast at $9,789,648,835.
In 2028, QTRX is forecast to generate $11,954,227,168 in revenue, with the lowest revenue forecast at $11,485,250,766 and the highest revenue forecast at $12,305,959,470.